Investing.com -- Adtalem Global Education Inc. (NYSE:ATGE) stock rose 6.4% on Monday after the healthcare education provider announced a new $750 million share repurchase authorization and completed its previous $150 million buyback program.
The company, which describes itself as America’s largest healthcare educator, said its board approved the new three-year authorization through December 2028, reflecting management’s confidence in Adtalem’s strategic direction and financial strength. Under the completed program, Adtalem repurchased approximately 1.6 million shares.
"Our operational execution continues to generate strong cash flow, giving us the flexibility to invest in significant growth opportunities while returning capital to shareholders in a tax-efficient manner," said Steve Beard, chairman and chief executive officer of Adtalem Global Education.
Since February 2022, the company has returned $913 million to shareholders by repurchasing 17.2 million shares at an average price of $52.95, representing a 30% reduction in shares outstanding. Adtalem currently has 34.9 million shares of common stock outstanding as of December 10, 2025.
The company has also strengthened its balance sheet, reducing debt by $1.1 billion since acquiring Walden University in August 2021. Current debt stands at $508.4 million as of October 31, 2025.
Adtalem plans to host an Investor Day on February 24, 2026, where it will provide a comprehensive strategic and operational update.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
